ArticleScientific reports2025
Ex vivo detection of SARS CoV 2 spike protein in human hair follicles and potential link to telogen effluvium.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Telogen effluvium (TE), a form of hair loss, has emerged in a subset of COVID-19 patients, typically occurring several weeks after infection. TE is characterized by premature entry of hair follicles (HFs) into the telogen phase of the hair cycle. We analyzed the expression of the viral entry factors ACE2 and TMPRSS2 in human scalp specimens. In cryosections of skin biopsies and plucked HFs, both proteins localized to the basal layer of the outer root sheath (ORS), with TMPRSS2 also present in Henle's layer of the inner root sheath (IRS). Ex vivo infection of plucked HFs with SARS-CoV-2 revealed nucleocapsid (NC) protein immunoreactivity in the ORS in two of three donors, corresponding to the K15⁺ epithelial stem/progenitor cell population. These NC⁺ cells co-expressed cleaved caspase3 (CAS3) and TUNEL, indicating apoptosis-related changes. Our findings suggest that SARS-CoV-2 nucleocapsid protein accumulates in ORS cells, potentially triggering local stress responses and apoptosis. This may provide a mechanistic link between SARS-CoV-2 infection and TE and highlights the HF as a potential, yet understudied, target organ in COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.